Aeovian
Biologics & Biosimilars · Health Care

Aeovian news and milestones

Aeovian: 6 headlines on record, 0 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 17, 2026 · Back to the company report
6Headlines
0In 90 days
1Milestones

Headlines

Dec 27, 20252025
News · Pulse 2.0
Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company based in Berkeley, California, has closed an oversubscribed $55 million Series B financing to support completi…
Dec 16, 20252025
News · YahooFinance
The TSC Alliance Endowment Fund, a supporting organization of the TSC Alliance, has invested in Aeovian Pharmaceuticals as part of their Series B financing in support of their Ph…
Apr 3, 20242024
News · Pulse 2.0
Aeovian Pharmaceuticals - a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway - announced that…
Mar 28, 20242024
Press release · PRNewswire
/PRNewswire/ -- Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit...
Dec 26, 20232023
News · bioworld.com
Aeovian Pharmaceuticals Inc. has disclosed new ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38) inhibitors reported to be useful for the treatment of neurodegenerative di…
Oct 12, 20192019
News · Chemical & Engineering News
Chemical & Engineering News (C&EN): Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Aeovian, News. Alion, Nov 17, 2026. https://alion.io/company/aeovian/news

.json · .md · CC BY-SA 4.0